Farther Finance Advisors, LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1992825 SAN FRANCISCO, CA

Position in COLL

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$386,158

-$87,352 QoQ

Shares Held

11,677

+14.2% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. COLL ranks #6 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,645	$1,376,555
2	VTRS	Viatris Inc	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp	818	$485,057
4	HIMS	Hims & Hers Health, Inc.	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc This page	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$386,158	11,677	+14.2%	Shares	Sole	2026-04-07
2025-12-31	$473,510	10,227	-11.2%	Shares	Sole	2026-01-23
2025-09-30	$402,874	11,514	-5.3%	Shares	Sole	2025-10-14
2025-06-30	$359,541	12,159	+9.6%	Shares	Sole	2025-07-11
2025-03-31	$331,066	11,091	+4.5%	Shares	Sole	2025-04-14
2024-12-31	$304,091	10,614	-9.1%	Shares	Sole	2025-02-10
2024-09-30	$451,237	11,678	+5408.5%	Shares	Sole	2024-10-29
2024-06-30	$6,826	212	+393.0%	Shares	Sole	2024-07-31
2024-03-31	$1,669	43	0.0%	Shares	Sole	2024-05-14
2023-12-31	$1,323	43	-57.0%	Shares	Sole	2024-02-15
2023-09-30	$2,235	100	0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,149	100	0.0%	Shares	Sole	2024-05-14
2023-03-31	$2,399	100	0.0%	Shares	Sole	2024-05-14
2022-12-31	$2,320	100	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.